Literature DB >> 6208022

Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid.

G Póvoa, G Enberg, H Jörnvall, K Hall.   

Abstract

Human amniotic fluid is rich in a binding protein for somatomedins. This binding protein competes with human placenta membranes for labelled somatomedin A. Consequently, the placenta radioreceptorassay for somatomedin can be used for detection of the binding protein. The protein was isolated from human amniotic fluid by a three-step procedure: First, stepwise ammonium sulphate precipitation; second, hydrophobic chromatography (phenyl-Sepharose); and third, anion-exchange chromatography (fast protein liquid chromatography). The total recovery of binding protein calculated with the placenta radioreceptorassay was 50%. Polyacrylamide gel electrophoresis under native and denaturating conditions of the isolated protein disclosed a single band. The relative molecular mass was 35000, determined by exclusion chromatography, and 32000 under denaturating conditions in sodium dodecyl sulphate/polyacrylamide gel electrophoresis. The isoelectric point was 4.3 according to chromatofocusing and the amino acid composition also disclosed a high content of acidic/amidated residues. The N-terminal amino acid sequence was Ala-Pro-Trp-Gln-Cys-Ala-Pro-Cys-Ser-Ala.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208022     DOI: 10.1111/j.1432-1033.1984.tb08449.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 2.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

3.  Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action.

Authors:  S Mohan; C M Bautista; J Wergedal; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus.

Authors:  K Brismar; M Gutniak; G Povoa; S Werner; K Hall
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

5.  Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation.

Authors:  C A Conover; F Liu; D Powell; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

Authors:  R G Elgin; W H Busby; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.

Authors:  L R Salgado; M Semer; M Nery; M Knoepfelmacher; A C Lerário; G Póvoa; S Jana; S M Villares; B L Wajchenberg; B Liberman; W Nicolau
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

8.  Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein.

Authors:  G T Ooi; A C Herington
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Cloning of cDNA encoding human placental protein 12 (PP12): binding protein for IGF I and somatomedin.

Authors:  U Grundmann; C Nerlich; H Bohn; T Rein
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

10.  Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Authors:  W H Daughaday; M Kapadia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.